Orchard Therapeutics (ORTX)
NASDAQ: ORTX
· Real-Time Price · USD
16.70
0.05 (0.30%)
At close: Jan 23, 2024, 10:00 PM
Orchard Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -72.92M | -85.17M | -123.78M | -150.66M | -179.13M | -168M | -153.7M | -144.58M | -141.86M | -125.7M | -136.59M |
Depreciation & Amortization | 2.67M | 2.67M | 2.67M | 2.74M | 2.7M | 2.69M | 2.54M | 2.33M | 2.1M | 1.93M | 2.02M |
Stock-Based Compensation | 12.48M | 13.48M | 14.86M | 16.01M | 17.42M | 19.34M | 20.93M | 22.54M | 23.94M | 24.21M | 24.75M |
Other Working Capital | 9.57M | -1M | 439K | 18.55M | 23K | 259.42M | 521.31M | 789.79M | 794.57M | 550.08M | 287.35M |
Other Non-Cash Items | -35.01M | -23.07M | 8.02M | 24.53M | 47.53M | 16.56M | 3.04M | 15K | -231K | 1.12M | -2.28M |
Deferred Income Tax | -4.48M | -5.15M | -5.36M | -4.81M | 1.16M | 12.51M | 12.9M | 11.67M | 5.28M | -5.78M | -679K |
Change in Working Capital | 3.93M | 9.88M | 17.68M | 36.2M | 13.02M | 21.12M | 8.83M | -17.06M | 7.24M | -9.34M | -2.83M |
Operating Cash Flow | -93.32M | -87.35M | -85.9M | -75.99M | -97.3M | -95.78M | -105.45M | -125.1M | -103.53M | -113.56M | -115.61M |
Capital Expenditures | -1.09M | -5.42M | -6.63M | -6.51M | -6.42M | -3.87M | -3.29M | -3.23M | -2.96M | -1.12M | -1.68M |
Cash Acquisitions | 23.85M | -16.27M | -43M | -51.83M | -50.94M | 1.77M | 1.77M | 1.77M | -204.11M | -205M | -205M |
Purchase of Investments | -187.75M | -175.95M | -121.43M | -112.28M | -92.77M | -147.8M | -163.17M | -263.88M | -279.37M | -230.73M | -194.16M |
Sales Maturities Of Investments | 154.85M | 183.18M | 176.2M | 201.39M | 206.08M | 198.44M | 242.72M | 234.73M | 257.91M | 246.8M | 260.49M |
Other Investing Acitivies | -15.88M | 24.24M | 50.97M | 59.8M | 50.94M | -1.76M | -1.56M | -1.56M | 204.33M | 205.2M | 157.38M |
Investing Cash Flow | -26.02M | 9.77M | 56.11M | 90.56M | 106.89M | 46.78M | 76.47M | -32.16M | -24.21M | 15.15M | 17.04M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | -921K | -927K | -50K | -38K | -19K | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 59.28M | 61.61M | 30.81M | -693K | 268K | 4.35M | 11.63M | 158.07M | 159.02M | 155.21M | 148.93M |
Financial Cash Flow | 59.28M | 61.61M | 30.81M | -693K | 268K | 4.35M | 11.63M | 158.07M | 159.02M | 155.21M | 148.93M |
Net Cash Flow | -57.33M | -15.25M | 661K | 12.46M | 6.43M | -46.46M | -18.11M | 777K | 33.16M | 58.76M | 51.78M |
Free Cash Flow | -94.41M | -92.78M | -92.53M | -82.5M | -103.72M | -99.65M | -108.75M | -128.33M | -106.49M | -114.67M | -117.29M |